# Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures

> **NCT01954121** · PHASE3 · COMPLETED · sponsor: **UCB Pharma SA** · enrollment: 436 (actual)

## Conditions studied

- Epilepsy
- Partial Seizures

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Carbamazepine

## Key facts

- **NCT ID:** NCT01954121
- **Lead sponsor:** UCB Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 436 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01954121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01954121, "Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01954121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*